CIK 0001759425
- Large accelerated filer
Mirum Pharmaceuticals, Inc.
Sign in to watch- Ticker
- MIRM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831281555
- Phone
- +1 650-667-4085
- Business address
- 989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY, CA, 94404
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,138,950
- in 5 filings, $4.8M under 10b5-1 plans
Net −$7,138,950. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-05 | GREY MICHAEL G Director | Grant or award · Stock Option (right to buy) | +8,779 | 8,779 | ||
| 2024-06-05 | GREY MICHAEL G Director | Grant or award · Deferred Stock Units | +5,703 | 5,703 | ||
| 2024-06-05 | Walbert Timothy P Director | Grant or award · Stock Option (right to buy) 10b5-1 | +8,779 | 8,779 | ||
| 2024-06-05 | Walbert Timothy P Director | Grant or award · Restricted Stock Units 10b5-1 | +5,703 | 5,703 | ||
| 2024-06-05 | Cardon Lon Director | Grant or award · Stock Option (right to buy) 10b5-1 | +8,779 | 8,779 | ||
| 2024-06-05 | Cardon Lon Director | Grant or award · Restricted Stock Units 10b5-1 | +5,703 | 5,703 | ||
| 2024-06-05 | Brege Laura Director | Grant or award · Stock Option (right to buy) 10b5-1 | +8,779 | 8,779 | ||
| 2024-06-05 | Brege Laura Director | Grant or award · Restricted Stock Units 10b5-1 | +5,703 | 5,703 | ||
| 2024-06-05 | Heron Patrick J Director | Grant or award · Stock Option (right to buy) 10b5-1 | +8,779 | 8,779 | ||
| 2024-06-05 | Heron Patrick J Director | Grant or award · Restricted Stock Units 10b5-1 | +5,703 | 5,703 | ||
| 2024-06-05 | Fischer Laurent Director | Grant or award · Stock Option (right to buy) | +8,779 | 8,779 | ||
| 2024-06-05 | Fischer Laurent Director | Grant or award · Deferred Stock Units | +5,703 | 5,703 | ||
| 2024-06-05 | Ramasastry Saira Director | Option exercise 10b5-1 | +5,000 | $14.12 | $71K | 5,000 |
| 2024-06-05 | Ramasastry Saira Director | Sale 10b5-1 | −5,000 | $25.68 | $128K | 0 |
| 2024-06-05 | Ramasastry Saira Director | Option exercise · Stock Option (right to buy) 10b5-1 | −5,000 | 2,500 | ||
| 2024-06-05 | Ramasastry Saira Director | Grant or award · Stock Option (right to buy) 10b5-1 | +8,779 | 8,779 | ||
| 2024-06-05 | Ramasastry Saira Director | Grant or award · Restricted Stock Units 10b5-1 | +5,703 | 5,703 | ||
| 2024-06-05 | Fairey William Director | Grant or award · Stock Option (right to buy) 10b5-1 | +8,779 | 8,779 | ||
| 2024-06-05 | Fairey William Director | Grant or award · Restricted Stock Units 10b5-1 | +5,703 | 5,703 | ||
| 2024-05-10 | BJERKHOLT ERIC CHIEF FINANCIAL OFFICER | Grant or award | +470 | $21.05 | $10K | 14,470 |
Page 18 of 25 · 490 trades